365 matches for your search in the start-up spotlight
rss
Refoxy is the first biotech company purposely developing FOXO3 activators to leverage the therapeutic effects related to this master regulator of biological homeostasis. Refoxy’s discovery platform, F.act finder (FOXO activator finder), delivers molecules that specifically modulate FOXO3 and ...
atbtherapeutics is a pioneering biopharmaceutical company building a pipeline of weaponized antibodies. Those novel therapeutic formats can only be achieved using our proprietary plant-based atbiofarm technology.
Inimmue is a new biotechnology company founded by pharmaceutical industry veterans focused on developing next generation immunotherapeutics.
Our mission at nuvalore is to create a perfect link between science and quality to ensure world-class laboratory services for companies in the pharmaceutical and life science industries. Through a fresh and innovative approach, we utilize cutting-edge technologies and proven methodologies to ...
Pentixapharm is a radiopharmaceutical development company founded in 2019, with its headquarters in Würzburg, Germany. Its clinical pipeline encompasses PentixaTher, an Yttrium-90 based therapeutic against CNS lymphoma, and PentixaFor, a Gallium-68 based companion diagnostic. Clinical studies for ...
HAYA Therapeutics is a precision medicines company developing programmable therapeutics targeting regulatory RNAs derived from the dark genome, a cell information processing unit, to reprogram pathological cell states for a broad range of diseases, including cardiovascular disease and cancer. The ...
At Panosome we are making the most challenging target classes such as carbohydrates, peptides and small molecules addressable to antibodies. Spun out of the German Cancer Research Center in 2020, we are using the revolutionary VAST technology to address antibody targets in several indications, ...
FLOWNETICS Engineering, a high-tech start-up from India, is currently setting the course for change and at the same time opening a window of fascinating opportunities for Pharma 4.0 and green chemistry. The company impresses with a consistent end-to-end offering from a single source and on a ...
FLOWNETICS Engineering, a high-tech start-up from India, is currently setting the course for change and at the same time opening a window of fascinating opportunities for Pharma 4.0 and green chemistry. The company impresses with a consistent end-to-end offering from a single source and on a ...
There are countless effective substances that could be used as highly efficient drugs - but they cannot be processed into drugs using typical drug formulations. One major hurdle is the limited number of excipients, such as polymers, that can be used for the production of drugs. The production of ...
